Celiac Disease Treatment Market Research Report: By Treatment, By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) – Forecast to 2027
Get a FREE Sample @ https://www.marketresearchfuture.com/sample_request/8474
It is expected that the Celiac Disease Treatment Market will register a higher CAGR of 18.60 per cent over the forecast period 2019-2025 and cross the US$661.2 million mark by 2025. The growing pediatric population is expected to grow the demand for treating celiac disease. It is projected that the increasing pediatric population will fuel growth in the future. It is projected that through clinical trials of drugs against celiac disease will affect the demand for treating celiac disease. During the forecast period, 2018-2025, the market is expected to see a move from symptomatic to targeted therapies.
Celiac Disease Treatment Market Key Players
Some of the key players in the global celiac disease treatment market are Amgen Inc. (US), Amneal Pharmaceuticals LLC (US), BioLineRx (Israel), Calypso Biotech SA (Switzerland), Freedom Foods Group Limited (Australia), General Mills, Inc. (US), Glenmark Pharmaceuticals Inc. (India), Hain Celestial Group, Inc. (US), Innovate Biopharmaceuticals Inc. (US), Kellogg Company (US), Mondelez International Inc. (US), Mylan Pharmaceuticals Inc. (US), Pinnacle Foods, Inc. (US), Selecta Biosciences, Inc (US), Takeda Pharmaceutical Company Ltd (Japan), The Kraft Heinz Company (US), West-Ward Pharmaceutical (US), Zedira GmbH (Germany), Zydus Pharmaceuticals Inc. (US), and others.
Celiac Disease Treatment Market Segmentation
The best way to cure celiac disease is to eliminate the gluten out of your diet completely. This helps the intestinal villi to heal properly and to start absorbing nutrients. For a clear understanding of the market, expert analysts have segmented the global celiac disease treatment market on the basis of treatment and end user. The market for celiac disease treatment, based on treatment, has been segmented into Gluten-Free Diet, enzyme supplement therapy and vitamin & mineral supplements, and medications. Additionally, the market on the basis of end users is further segmented into Hospitals and clinics, Research & Academic Institutes, and Clinical Research Organizations.
Celiac Disease Treatment Market Regional Overview
Americas is the area's main celiac care market. Rising the prevalence of celiac disease as well as the existence of key players on the market. Are driving the market in the area. The prevalence of celiac disease inside South Africa is projected to be as high as 4.0 per cent. Preceded by the Americas, Europe ranks second in the worldwide market for celiac disease treatment. Increasing healthcare spending and the emergence of developing economies are driving the European market for treating celiac disease. In 2016 the per capita healthcare spending in Europe was ~US$5,490.1. Asia-Pacific is expected to be the region's fastest-growing market for treating celiac disease. Underdeveloped Middle East and Africa area supply chain makes it very hard for the manufacturers to meet their customers' demand.
Celiac Disease Treatment Industry News
Researchers were investigating how bacteria in the gut, particularly bifidobacteria, can be used as a medication. Today, in ACS' Journal of Agricultural and Food Chemistry, researchers reporting the findings of laboratory studies study how different forms of bifidobacteria work.
Access Full Report Details @ https://www.marketresearchfuture.com/reports/celiac-disease-treatment-market-8474
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
